Biolinerx Stock Probability of Future Stock Price Finishing Over 0.25
| BLRX Stock | USD 0.27 0.01 3.57% |
BioLineRx |
BioLineRx Target Price Odds to finish over 0.25
The tendency of BioLineRx Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to stay above $ 0.25 in 90 days |
| 0.27 | 90 days | 0.25 | close to 99 |
Based on a normal probability distribution, the odds of BioLineRx to stay above $ 0.25 in 90 days from now is close to 99 (This BioLineRx probability density function shows the probability of BioLineRx Stock to fall within a particular range of prices over 90 days) . Probability of BioLineRx price to stay between $ 0.25 and its current price of $0.27 at the end of the 90-day period is near 1 .
Given the investment horizon of 90 days BioLineRx has a beta of -0.39 suggesting as returns on the benchmark increase, returns on holding BioLineRx are expected to decrease at a much lower rate. During a bear market, however, BioLineRx is likely to outperform the market. Additionally BioLineRx has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. BioLineRx Price Density |
| Price |
Predictive Modules for BioLineRx
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as BioLineRx. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.BioLineRx Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. BioLineRx is not an exception. The market had few large corrections towards the BioLineRx's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold BioLineRx, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of BioLineRx within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -1.2 | |
β | Beta against Dow Jones | -0.39 | |
σ | Overall volatility | 0.11 | |
Ir | Information ratio | -0.2 |
BioLineRx Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of BioLineRx for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for BioLineRx can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| BioLineRx generated a negative expected return over the last 90 days | |
| BioLineRx has high historical volatility and very poor performance | |
| BioLineRx has some characteristics of a very speculative penny stock | |
| BioLineRx has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 4.8 M. Net Loss for the year was (60.61 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| BioLineRx currently holds about 43.15 M in cash with (22.61 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.9, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| BioLineRx has a frail financial position based on the latest SEC disclosures | |
| Latest headline from seekingalpha.com: BioLineRx Q3 2024 Earnings Preview |
BioLineRx Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of BioLineRx Stock often depends not only on the future outlook of the current and potential BioLineRx's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. BioLineRx's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 64.2 M | |
| Cash And Short Term Investments | 43 M |
BioLineRx Technical Analysis
BioLineRx's future price can be derived by breaking down and analyzing its technical indicators over time. BioLineRx Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of BioLineRx. In general, you should focus on analyzing BioLineRx Stock price patterns and their correlations with different microeconomic environments and drivers.
BioLineRx Predictive Forecast Models
BioLineRx's time-series forecasting models is one of many BioLineRx's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary BioLineRx's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about BioLineRx
Checking the ongoing alerts about BioLineRx for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for BioLineRx help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| BioLineRx generated a negative expected return over the last 90 days | |
| BioLineRx has high historical volatility and very poor performance | |
| BioLineRx has some characteristics of a very speculative penny stock | |
| BioLineRx has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 4.8 M. Net Loss for the year was (60.61 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| BioLineRx currently holds about 43.15 M in cash with (22.61 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.9, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| BioLineRx has a frail financial position based on the latest SEC disclosures | |
| Latest headline from seekingalpha.com: BioLineRx Q3 2024 Earnings Preview |
Additional Tools for BioLineRx Stock Analysis
When running BioLineRx's price analysis, check to measure BioLineRx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioLineRx is operating at the current time. Most of BioLineRx's value examination focuses on studying past and present price action to predict the probability of BioLineRx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioLineRx's price. Additionally, you may evaluate how the addition of BioLineRx to your portfolios can decrease your overall portfolio volatility.